-
Febuxostat, sold
under the
brand name
Uloric among others, is a
medication used long-term to
treat gout due to high uric acid levels. It is
generally recommended...
- Thai descent.
Febuxostat is only
recommended in
those who
cannot tolerate allopurinol.
There are
concerns about more
deaths with
febuxostat compared to...
- term. They
include uricostatic agents, in
particular allopurinol and
Febuxostat, and
uricosuric agents, such as
probenecid and benzbromarone. Induction...
-
medicines that
decrease the
production of uric acid (e.g., allopurinol,
febuxostat) or
increase uric acid
elimination from the body
through the
kidneys (e...
-
analogues include allopurinol, oxypurinol, and tisopurine.
Others include febuxostat, topiroxostat, and
inositols (phytic acid and myo-inositol[citation needed])...
- gout. It is
recommended only as an
adjuvant with
either allopurinol or
febuxostat when
these medications are not sufficient. It
received FDA
approval on...
-
medications is not clear.
Xanthine oxidase inhibitors,
including allopurinol,
febuxostat and topiroxostat,
decrease the
production of uric acid, by interfering...
-
Phase 3
clinical trials to
evaluate its
efficacy and
safety compared to
febuxostat in gout
patients across multiple Asian countries. "JW Pharmaceutical's...
- (CA). 124: 2235.
December 2014.
Retrieved 2016-11-07. "Prophylaxis with
Febuxostat in
comparison to
Allopurinol reduces exposure to uric acid in patients...
-
follows the WHO version. M04AA01
Allopurinol M04AA02
Tisopurine M04AA03
Febuxostat M04AA51 Allopurinol,
combinations M04AB01
Probenecid M04AB02 Sulfinpyrazone...
